Anzeige
Mehr »
Freitag, 06.06.2025 - Börsentäglich über 12.000 News
Starke Zahlen: EBITDA bei 9 Mio.?€ - Startet jetzt die Neubewertung?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A3DTRX | ISIN: US92854B1098 | Ticker-Symbol: U5P
Tradegate
04.06.25 | 11:28
0,975 Euro
-2,50 % -0,025
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
VIVANI MEDICAL INC Chart 1 Jahr
5-Tage-Chart
VIVANI MEDICAL INC 5-Tage-Chart
RealtimeGeldBriefZeit
0,9901,04017:12
0,9901,04016:54

Aktuelle News zur VIVANI MEDICAL Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
MoVivani Stock Gains After Announcing Spin-Off Plans for Cortigent Unit2
29.05.Vivani files with SEC to spin off neurostim business, focus on drug delivery implants2
29.05.Vivani Medical spins off Cortigent as independent company3
29.05.Vivani Medical gliedert Cortigent als unabhängiges Unternehmen aus2
29.05.Vivani Medical, Inc. - 8-K, Current Report1
29.05.Vivani Medical, Inc.: Vivani Medical Announces Filing of Form 10 Registration Statement for Planned Spin-Off of Cortigent Neurostimulation Business to Vivani Shareholders100Transaction is anticipated to be completed in third quarter 2025 Planned Cortigent Nasdaq listing intended to drive value for Vivani and Cortigent stockholders Cortigent is developing the Orion® Visual...
► Artikel lesen
13.05.Vivani Medical GAAP EPS of -$0.11 misses by $0.012
13.05.Vivani Medical, Inc. - 10-Q, Quarterly Report1
VIVANI MEDICAL Aktie jetzt für 0€ handeln
13.05.Vivani Medical, Inc. - 8-K, Current Report1
13.05.Vivani Medical, Inc.: Vivani Medical Provides Business Update Including $3M Equity Financing and Reports First Quarter 2025 Financial Results158All subjects in the NPM-115 cohort had successful insertions of a miniature, ultra long-acting GLP-1 (exenatide) implant in the on-going LIBERATE-1 study in obese or overweight individuals; top-line...
► Artikel lesen
07.05.Vivani Medical, Inc.: Vivani Medical to Present at the American Association of Pharmaceutical Scientists' "Beyond GLP1s: Where the Science will Take Business Next" Virtual Workshop3
16.04.Vivani Medical, Inc.: Vivani Medical to Participate in Virtual Fireside Chat Hosted by H.C. Wainwright & Company2
15.04.Vivani Medical erweitert Partnerschaft mit Okava für Hundetherapie-
15.04.Vivani Medical expands partnership with Okava for dog therapy2
15.04.Vivani Medical, Inc. - 8-K, Current Report2
15.04.Vivani Medical, Inc.: Vivani Medical and Okava Expand Collaboration to Develop OKV-119 for Dogs, Targeting Metabolic Health and Longevity165ALAMEDA, Calif. and SAN FRANCISCO, April 15, 2025 (GLOBE NEWSWIRE) -- Vivani Medical, Inc. (NASDAQ: VANI) ("Vivani" or the "Company"), a clinical-stage biopharmaceutical company developing miniature...
► Artikel lesen
15.04.EXCLUSIVE: Vivani Medical Collaborates With Okava To Expand Development Of GLP-1 Therapy For Dogs2
04.04.H.C. Wainwright maintains Buy on Vivani Medical stock, $4 target1
31.03.Vivani Medical, Inc. - 10-K, Annual Report2
31.03.Vivani Medical, Inc. Loss At -$6.05 Mln In Q42
Weiter >>
49 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1